MARC details
| 000 -LEADER |
|---|
| fixed length control field |
02990nam a22003017a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
ZW-GwMSU |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20241004080433.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
241002b |||||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781394168156 |
| Qualifying information |
(paperback) |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
rda |
| Language of cataloging |
English |
| Description conventions |
rda |
| Transcribing agency |
MSULIB |
| 050 00 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RC633.H63 HOF |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Hoffbrand, A. V., |
| Relator term |
author. |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Hoffbrand's essential haematology / |
| Statement of responsibility, etc. |
created by A. Victor Hoffbrand ; contributing authors, Pratima Chowdary, Graham Collins, Justin Loke. |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
Ninth edition. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
Hoboken, NJ : |
| Name of producer, publisher, distributor, manufacturer |
Wiley-Blackwell |
| Date of production, publication, distribution, manufacture, or copyright notice |
2024. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
490 pages : |
| Other physical details |
illustrations ; |
| Dimensions |
29 cm |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Content type code |
txt |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
unmediated |
| Media type code |
n |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
volume |
| Carrier type code |
nc |
| Source |
rdacarrier |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Includes bibliographical references and index. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Haemopoiesis -- Erythropoiesis and general aspects of anaemia -- Hypochromic anaemias -- Iron overload -- Megaloblastic anaemias and other macrocytic anaemias -- Haemolytic anaemias -- Genetic disorders of haemoglobin -- The white cells, part 1 : granulocytes, monocytes and their benign disorders -- The white cells, part 2 : lymphocytes and their benign disorders -- The Spleen -- The aetiology and genetics of haematological neoplasia -- Management of haematological malignancy -- Acute myeloid leukaemia -- Chronic myeloid leukaemia -- Myeloproliferative neoplasms -- Myelodysplastic neoplasias -- Acute lymphoblastic leukaemia -- The chronic lymphocytic leukaemias -- Hodgkin Lymphoma -- Non-Hodgkin lymphomas 1: General aspects -- Non-Hodgkin lymphomas -- Multiple myeloma and related plasma cell neoplasms -- Amyloid -- Aplastic anaemia and bone marrow failure syndromes -- Haemopoietic stem cell transplantation -- Platelets, coagulation and normal haemostasis -- Bleeding disorders caused by platelet and vascular abnormalities -- Hereditary coagulation disorders -- Acquired coagulation disorders and thrombotic microangiopathies -- Thrombosis 1 : Pathogenesis and diagnosis -- Thrombosis 2 : Treatment -- Haematological changes in systemic diseases -- Blood transfusion -- Pregnancy and neonatal haematology. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
"Advances in the understanding the pathogenesis of blood diseases and improvements in their treatment have continued apace in the five years since the 8th edition of HEH was published. Gene mutations are increasingly used to define and classify inherited and acquired haematological diseases, as a guide to therapy and to predict prognosis. Mutations underlying many rarer blood diseases have been identified, allowing appropriate panels of DNA probes to be established, facilitating the diagnosis of future cases. Many more drugs directed against specific sites in the cell signalling pathways have been approved"-- |
| Assigning source |
Provided by publisher. |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Hematologic Diseases |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Chowdary, Pratima, |
| Relator term |
author. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Collins, Graham |
| Titles and other words associated with a name |
(Hematologist) |
| Relator term |
author. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Loke, Justin, |
| Dates associated with a name |
1984- |
| Relator term |
author. |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Library of Congress Classification |
| Koha item type |
Book |